• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


The Ritedose Corporation Expands Columbia, South Carolina, Operations

The Ritedose Corporation, a locally owned and operated pharmaceutical manufacturer, will expand operations in Richland County, South Carolina. The $81 million project is expected to create 94 new jobs.

Located at Carolina Research Park in Columbia, the investment includes adding square footage to the facility as well as internal renovations to the existing structures. Phase one of the expansion, scheduled for completion in early 2024, will allow the company to manufacture an additional 400 million doses of pharmaceuticals.

“This initial phase of the expansion project will allow The Ritedose Corporation to continue to deliver over 1 billion doses of respiratory maintenance drugs to the U.S. population, while providing the runway for multiple drugs in various stages of development to be commercialized in the coming years,” said The Ritedose Corporation President and CEO Jody Chastain.

The Coordinating Council for Economic Development approved job development credits related to this project. The council also awarded a $500,000 Set-Aside grant to Richland County to assist with the costs of building improvements.

“The Ritedose Corporation, a homegrown pharmaceutical leader whose expansion signals the strength of our state’s growing life sciences industry. This investment also expands STEM career pathways for all South Carolinians, nurturing the highly skilled workforce within our state. We’re proud of the continued success of yet another South Carolina-based company,” noted Secretary of Commerce Harry M. Lightsey III.

Founded in 1995, The Ritedose Corporation operates a state-of-the-art “blow-fill-seal” (BFS) facility, where liquid-pharmaceuticals are formulated, filled and packaged for distribution. The company has been an industry leader in the aseptic production of sterile, single-dose medication, serving the contract development manufacturing, generics and 503B outsourcing markets. The Ritedose Corporation’s customers range from small startups and retail pharmacies to large pharmaceutical companies, wholesalers and hospital systems.

Exclusive Research